Biogen soars 13% on report of potential acquisition by South Korea's Samsung Group

A sign marks a Biogen facility in CambridgeReutersBiogen soared as much as 13% on Wednesday following a report of potential buyout interest.The Korea Economic Daily said South Korea's Samsung Group is in negotiations to buy Biogen.A potential deal would value the drug maker at more than $40 billion, according to the report.Sign up here for our daily newsletter, 10 Things Before the Opening Bell.Biogen stock soared as much as 13% on Wednesday following a Korea Economic Daily report that Samsung G